Dual-modality breast cancer screening compared to MRI or mammography alone among female Hodgkin lymphoma survivors who received chest radiotherapy

Key Points

• Dual-modality screening shows promising accuracy for breast cancer detection in female Hodgkin lymphoma survivors.
• Mammography alone had a detection rate of 68% while MRI alone was at 85%, highlighting better results with dual-modality.
• This analysis evaluated the effectiveness of dual-modality screening versus MRI or mammography alone in survivors of Hodgkin lymphoma.
• Findings suggest that dual-modality screening may enhance early detection, though further studies are warranted.